September 8, 2016
Cambridge, MA

Solid Observes World Duchenne Awareness Day

On Wednesday, September 7, 2016, Solid Biosciences joined the Jett Foundation and other members of the local Cambridge, MA community to observe World Duchenne Awareness Day.

The event convened many of those impacted by the disease - patients, families, industry, researchers, healthcare providers and local policy representatives - to show unity in finding a cure for Duchenne muscular dystrophy and demonstrate that innovation takes unfailing drive and commitment. It also celebrated Cambridge as a center of innovation in Duchenne muscular dystrophy.

Solid Biosciences joined the Jett Foundation and other members of the local Cambridge, MA community to observe World Duchenne Awareness Day 2016.

With the great city of Boston as a backdrop, the group came together and raised red lanterns along the Charles River, honoring those with Duchenne muscular dystrophy and celebrating hope for the future.

Follow the event on Twitter #WDAD16 and #DuchenneCambridge.

Related news


Today we are excited to announce the initiation of our first clinical trial for SGT-001.


Phase I/II adaptive clinical trial to evaluate safety and efficacy in ambulatory and non-ambulatory children and adolescents.


Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. 


New data from the SGT-001 preclinical program was published today in Molecular Therapy – Methods and Clinical Development


We are getting ready to initiate a clinical study for our gene transfer candidate, SGT-001, later this year.


Solid Biosciences is pleased to announce additional research grant from our Australia-based partner Save Our Sons and an initial research grant from Ireland-based Join Our Boys.

  • Jennifer Ziolkowski, CPA, joins as Chief Financial Officer.
  • Carl Morris, Ph.D., promoted to Chief Scientific Officer.
  • Joel Schneider, Ph.D., promoted to Chief Technology Officer, Head of Exploratory R&D.

Company to Use Proceeds to Advance Programs for Duchenne Muscular Dystrophy.


Solid Biosciences is proud to join the global Rare Disease community to recognize Rare Disease Day 2017.


As we move into 2017, I want to reflect on our journey since founding Solid three years ago and to outline what we hope to accomplish in the coming year.


More information about Solid?

Please subscribe to receive our latest news